Role of ZBP1 in pathogenesis of Salmonella biofilms
Role of ZBP1 in pathogenesis of Salmonella biofilms
批准号:
10658383
负责人:
SIDDHARTH BALACHANDRAN
金额:
$84.61万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-11 至 2028-04-30
关键词:
AcuteAmyloidAnkylosing spondylitisAutoantibodiesAutoimmunityB-DNABacterial DNABacterial InfectionsBindingCampylobacterCell DeathCellsCessation of lifeChronicClinicalComplexDNADiseaseEpithelial CellsFibroblastsGastrointestinal tract structureGenerationsGenomic DNAHumanIL17 geneImmuneIndividualIndustrializationInfectionInflammationInflammation MediatorsInflammatoryInterferon Type ILeftLigandsMediatingMicrobial BiofilmsMorbidity - disease rateMusNatureNucleic AcidsOutcomePainPathogenesisPathway interactionsPatientsPhenotypePhosphotransferasesPositioning AttributePreventiveProcessProductionProtein SecretionProteinsRIPK3 geneRNAReiter DiseaseReportingRoleSalmonellaSalmonella entericaSalmonella infectionsSalmonella typhimuriumShigellaSignal TransductionSymptomsTestingTherapeuticTherapeutically TargetableViral ProteinsVirus DiseasesYersiniaZ-Form DNAacute infectioncell typechronic infectionchronic inflammatory diseaseds-DNAenteric infectionenteric pathogengastrointestinal symptomimmunogenicinhibitorintestinal epitheliumjoint inflammationkinase inhibitormodel organismmortalitymouse modelmutantnovel therapeuticspreventresponsesensorsmall moleculesystemic inflammatory response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Infections with enteric pathogens such as Salmonella, Campylobacter, Shigella, or Yersinia are leading causes
of morbidity and mortality worldwide. Although in most individuals the infection resolves, approximately 5% of
patients subsequently develop a painful chronic inflammatory condition known as Reactive Arthritis (ReA). How
Salmonella infections trigger ReA is not well understood. Using Salmonella enterica serovar Typhimurium (STm)
as a model organism, we discovered that a Salmonella protein, curli, is a dominant instigator of inflammation
following Salmonella infection. Curli is a secreted protein and major component of the STm biofilm in the
gastrointestinal tract. Curli fibrils bind extruded bacterial DNA within the biofilm. It is these curli:DNA complexes,
rather than curli alone, that are potent triggers of type I interferon, IL-17, and anti-double stranded DNA
autoantibody production, leading to ReA. Unknown, however, is why curli:DNA complexes are so inflammatory.
We report in this proposal the remarkable discovery that the DNA present within curli:DNA complexes is not
solely B-DNA, the classic right-handed (Watson-Crick) double-helix, but includes copious amounts of left-handed
Z-DNA as well. Z-form nucleic acids, such as Z-DNA and Z-RNA, were thought not to readily occur in nature,
until we showed last year that Z-RNA is indeed produced during virus infections and is a ligand for the
necroptosis-activating host sensor protein ZBP1. Our preliminary results now show that the Z-DNA within
curli:DNA complexes activates ZBP1 in intestinal epithelial cells (IECs) and fibroblasts, resulting in RIPK3-
dependent necroptosis of these cells. These findings allow us to put forward the hypothesis that Z-DNA within
curli:DNA fibrils in Salmonella biofilms activates ZBP1 to instigate RIPK3-dependent necroptosis in intestinal
epithelial cells (IECs) and other cell types. Necroptosis, in turn, causes cell loss and disrupts gut barrier integrity,
releasing inflammatory mediators that eventually result in autoimmunity and ReA. As necroptosis is a highly
inflammatory mode of cell death, these findings, at long last, supply a plausible mechanism for why curli:DNA
complexes are hyperinflammatory, and, therefore, for how Salmonella triggers ReA. They also identify Z-DNA
as a new PAMP, implicate ZBP1 – until now considered an antiviral protein – as a sensor of bacterial infections,
and position RIPK3 inhibitors as unanticipated new therapeutics for the treatment of ReA. In aim 1, we will
determine how Z-DNA forms within curli:DNA complexes, and how Z-DNA activates ZBP1. In aim 2, we will
identify the ZBP1-driven immune pathways that promote curli:DNA induced inflammation and ReA, and
determine the cell types in which ZBP1 signaling is important for pathogenesis. In aim 3, we will evaluate whether
necroptosis blockade with RIPK3 kinase inhibitors will have preventive or therapeutic benefit in ReA. A
successful outcome to these studies will outline an entirely new mechanism of Salmonella-triggered
inflammation. They also stand to open up exciting new therapeutic avenues for Salmonella-induced ReA, with
potentially game-changing ramifications for this currently incurable disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
-
批准号:10586659
-
项目类别:
-
资助金额:$75.9万
-
财政年份:2023
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Harnessing ZBP1-triggered cell death to enhance influenza vaccine responsiveness
-
批准号:10884586
-
项目类别:
-
资助金额:$83.35万
-
财政年份:2023
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy
-
批准号:10557863
-
项目类别:
-
资助金额:$23.3万
-
财政年份:2022
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy
-
批准号:10433040
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2022
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Harnessing ZBP1-driven cell death to improve influenza vaccine efficacy
-
批准号:10455196
-
项目类别:
-
资助金额:$84.79万
-
财政年份:2021
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Targeting RIPK3 in Flu-Associated Lung Injury
-
批准号:10020307
-
项目类别:
-
资助金额:$67.89万
-
财政年份:2019
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Targeting RIPK3 in Flu-Associated Lung Injury
-
批准号:10470746
-
项目类别:
-
资助金额:$73.17万
-
财政年份:2019
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Targeting RIPK3 in Flu-Associated Lung Injury
-
批准号:10689229
-
项目类别:
-
资助金额:$70.2万
-
财政年份:2019
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Targeting RIPK3 in Flu-Associated Lung Injury
-
批准号:10238084
-
项目类别:
-
资助金额:$78.93万
-
财政年份:2019
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death
-
批准号:10247652
-
项目类别:
-
资助金额:$57.79万
-
财政年份:2017
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death
-
批准号:9761976
-
项目类别:
-
资助金额:$66.71万
-
财政年份:2017
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death
-
批准号:10610449
-
项目类别:
-
资助金额:$72.03万
-
财政年份:2017
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death
-
批准号:10446481
-
项目类别:
-
资助金额:$74.23万
-
财政年份:2017
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
RIP1/3 Kinases as New Targets in Malignant Mesothelioma
-
批准号:8799710
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2015
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Control of interferon-activated necrosis by a virus-triggered FADD checkpoint
-
批准号:8770320
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2014
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer
-
批准号:8829193
-
项目类别:
-
资助金额:$37.04万
-
财政年份:2014
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Picornavirus-initiated inflamation: novel parallels from Drosophila
-
批准号:8444160
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2013
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Picornavirus-initiated inflamation: novel parallels from Drosophila
-
批准号:8608479
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2013
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Blood Cell Development and Function Program (02)
-
批准号:10427547
-
项目类别:
-
资助金额:$1.43万
-
财政年份:1997
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
Blood Cell Development and Function Program (02)
-
批准号:9147891
-
项目类别:
-
资助金额:$3.18万
-
财政年份:--
-
负责人:SIDDHARTH BALACHANDRAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
-
批准号:22077118
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:高楠
-
依托单位:
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
-
批准号:81870666
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:王海燕
-
依托单位:
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
-
批准号:81601123
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:都瑾
-
依托单位:
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
-
批准号:30971012
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:刘瑞田
-
依托单位:
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
-
批准号:30570622
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2005
-
负责人:刘瑞田
-
依托单位: